DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir Sulfate) - Current Clinical Trials


Reyataz Related Clinical Trials

Atazanavir Twice Daily [Completed]

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV [Active, not recruiting]

Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone [Completed]

Drug Interaction Study With Proton Pump Inhibitor [Completed]

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects [Completed]

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients [Completed]

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients [Completed]

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. [Recruiting]

Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study [Active, not recruiting]

ATV/Ritonavir Nevirapine Interaction (USPAC) [Completed]

The Effects of Atazanavir-Induced Hyperbilirubinemia During Human Endotoxemia [Recruiting]

Atazanavir and Lamivudine for Treatment Simplification [Not yet recruiting]

Effects of Gastric pH on the Pharmacokinetics of Atazanavir [Recruiting]

Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir [Completed]

Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression [Recruiting]

Drug Interactions Between Atazanavir Plus Ritonavir Coadministered With Voriconazole in Healthy Subjects [Recruiting]

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) [Completed]

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens [Recruiting]

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females [Completed]

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV Infected Infants, Children, and Adolescents [Active, not recruiting]

PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV) [Not yet recruiting]

Study of Reyataz in HIV-Infected Patients With Lipodystrophy Syndrome [Active, not recruiting]

Bioequivalence Study of Atazanavir 300 mg Capsule [Completed]

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women [Recruiting]

Atazanavir/Ritonavir (ATV/RTV) Once a Day (QD) + Raltegravir (RAL) Twice a Day (BID) Stable Switch Study [Recruiting]

Switch to Unboosted Atazanavir With Tenofovir Study [Recruiting]

Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment [Recruiting]

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients [Terminated]

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) [Recruiting]

Study to Evaluate the Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Infected Subjects Evidencing Virologic Suppression [Active, not recruiting]

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression [Recruiting]

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [Completed]

A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy [Completed]

Study of Boosted Atazanavir (ATV) Versus Non-Boosted ATV in Naive Patients [Completed]

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2) [Recruiting]

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients [Suspended]

Raltegravir and Atazanavir Dosing Strategy Study [Recruiting]

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada [Active, not recruiting]

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir [Not yet recruiting]

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe [Recruiting]

Metabolic Effects of Switching Kaletra to Boosted Reyataz [Recruiting]

Atazanavir/Ritonavir and Zinc Pharmacokinetic Study [Not yet recruiting]

Phase IIB Pilot of Atazanavir + Raltegravir [Recruiting]

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients [Recruiting]

Raltegravir vs. Atazanavir in Combination With Truvada� for the Treatment of Antiretroviral na�ve HIV Infected Patients [Recruiting]

Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression [Recruiting]

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Active, not recruiting]

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study [Completed]

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir DF in HIV-1-Infected Treatment Naive Adults [Active, not recruiting]

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients [Completed]

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Active, not recruiting]

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Recruiting]

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) [Recruiting]

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy [Recruiting]

DDI HV (ATV - Merck) [Completed]

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-Infected Patients That Have Never Received Treatment. [Recruiting]

Drug Interaction Study [Active, not recruiting]

A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [Completed]

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [Terminated]

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients [Recruiting]

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV [Completed]

Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction [Recruiting]

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen [Completed]

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes [Recruiting]

Pilot Study of a Raltegravir Based NRTI Sparing Regimen [Recruiting]

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [Completed]

A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome [Completed]

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [Completed]

"The Once A Day Protease Inhibitor Regimens" [Active, not recruiting]

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients [Completed]

Atazanavir or Lopinavir in HIV Post-Exposure Prophylaxis [Not yet recruiting]

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study [Active, not recruiting]

Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults [Recruiting]

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults [Active, not recruiting]

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women [Recruiting]

Atazanavir/Ritonavir Maintenance Therapy [Active, not recruiting]

Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-na�ve Subjects With Low CD4 Counts [Recruiting]

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV [Recruiting]

Atazanavir for HIV Infected Individuals: An Early Access Program

Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers [Not yet recruiting]

Standard Antiretroviral v. Multi-Class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) [Recruiting]

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir [Recruiting]

Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population [Recruiting]

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy [Recruiting]

Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir [Recruiting]

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r [Recruiting]

Evaluation of Atazanavir Substitution Intervention (EASI) Study [Recruiting]

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Active, not recruiting]

Taste Properties of Atazanavir and Cobicistat [Not yet recruiting]

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients [Completed]

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users [Recruiting]

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients [Not yet recruiting]

Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects [Recruiting]

Korean Post-marketing Surveillance for Reyataz [Recruiting]

Study to Evaluate a HIV Drug for the Treatment of HIV Infection [Recruiting]

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Recruiting]

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir [No longer recruiting]

Safety Study of Raltegravir in HIV/HCV Co-infected Patients [Recruiting]

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women [Recruiting]

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in HIV Infected Naive Patients (NEwArT) [Recruiting]

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015